🎉 M&A multiples are live!
Check it out!

Alicorp Valuation Multiples

Discover revenue and EBITDA valuation multiples for Alicorp and similar public comparables like EZZ Life Science, Sarantis Group, and Acme United.

Alicorp Overview

About Alicorp

Alicorp SA is a Peruvian company that manufactures, imports, exports and distributes mass consumption products across South America. Products are offered through four operating segments: mass Consumption, which contributes to the majority of firm revenue, B2B and aquaculture. Mass consumption products include various oils, hair care products, noodles, drinks, and food products. The B2B segment is the next contributor to revenue and manufactures and supplies products for industrial use such as laundry detergents, soap and stain removers, as well as beauty products. Aquaculture involves the provision of nutritional animal food and the Grinding segment. The company earns the majority of revenue domestically, with the rest coming from other South American countries.


Founded

1956

HQ

Peru
Employees

5.4K+

Website

alicorp.com.pe

Financials

LTM Revenue $3.5B

LTM EBITDA $523M

EV

$2.6B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Alicorp Financials

As of September 2025, Alicorp reported last 12-month revenue of $3.5B and EBITDA of $523M.

In the same period, Alicorp achieved $188M in LTM net income.

See Alicorp valuation multiples based on analyst estimates

Alicorp P&L

In the most recent fiscal year, Alicorp reported revenue of $3.1B and EBITDA of $324M.

Alicorp expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Alicorp valuation multiples based on analyst estimates
LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $3.5B XXX $3.1B XXX XXX XXX
Gross Profit n/a XXX $850M XXX XXX XXX
Gross Margin n/a XXX 27% XXX XXX XXX
EBITDA $523M XXX $324M XXX XXX XXX
EBITDA Margin 15% XXX 10% XXX XXX XXX
EBIT $402M XXX $346M XXX XXX XXX
EBIT Margin 11% XXX 11% XXX XXX XXX
Net Profit $188M XXX $104M XXX XXX XXX
Net Margin 5% XXX 3% XXX XXX XXX
Net Debt XXX XXX $860M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Alicorp Stock Performance

Alicorp has current market cap of PEN 5.4B (or $1.6B), and EV of PEN 8.9B (or $2.6B).

Market Cap Evolution

Alicorp Stock Data

As of October 17, 2025, Alicorp's stock price is PEN 9 (or $3).

See Alicorp trading valuation data
EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$2.6B $1.6B XXX XXX XXX XXX $0.35

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Alicorp Valuation Multiples

Alicorp's trades at 0.8x EV/Revenue multiple, and 8.2x EV/EBITDA.

See valuation multiples for Alicorp and 15K+ public comps

Alicorp Financial Valuation Multiples

As of October 17, 2025, Alicorp has market cap of $1.6B and EV of $2.6B.

Equity research analysts estimate Alicorp's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Alicorp has a P/E ratio of 8.5x.

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $1.6B XXX $1.6B XXX XXX XXX
EV (current) $2.6B XXX $2.6B XXX XXX XXX
EV/Revenue 0.8x XXX 0.8x XXX XXX XXX
EV/EBITDA 5.1x XXX 8.2x XXX XXX XXX
EV/EBIT 6.6x XXX 7.6x XXX XXX XXX
EV/Gross Profit n/a XXX n/a XXX XXX XXX
P/E 8.5x XXX 15.4x XXX XXX XXX
EV/FCF n/a XXX 4.5x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Alicorp Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Alicorp Margins & Growth Rates

Alicorp's last 12 month revenue growth is 8%

Alicorp's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.1M for the same period.

Alicorp's rule of 40 is 14% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Alicorp's rule of X is 34% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Alicorp and other 15K+ public comps

Alicorp Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth 8% XXX 10% XXX XXX XXX
EBITDA Margin 15% XXX 10% XXX XXX XXX
EBITDA Growth 6% XXX 42% XXX XXX XXX
Rule of 40 14% XXX 18% XXX XXX XXX
Bessemer Rule of X XXX XXX 34% XXX XXX XXX
Revenue per Employee XXX XXX $0.6M XXX XXX XXX
Opex per Employee XXX XXX $0.1M XXX XXX XXX
S&M Expenses to Revenue XXX XXX 8% XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX n/a XXX XXX XXX
Opex to Revenue XXX XXX 16% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Alicorp Public Comps

See public comps and valuation multiples for Health & Beauty and Home Care comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Acme United XXX XXX XXX XXX XXX XXX
EZZ Life Science XXX XXX XXX XXX XXX XXX
Lavipharm XXX XXX XXX XXX XXX XXX
Sarantis Group XXX XXX XXX XXX XXX XXX
SynBiotic XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Alicorp M&A and Investment Activity

Alicorp acquired  XXX companies to date.

Last acquisition by Alicorp was  XXXXXXXX, XXXXX XXXXX XXXXXX . Alicorp acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Alicorp

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.

Start Free Trial

About Alicorp

When was Alicorp founded? Alicorp was founded in 1956.
Where is Alicorp headquartered? Alicorp is headquartered in Peru.
How many employees does Alicorp have? As of today, Alicorp has 5.4K+ employees.
Is Alicorp publicy listed? Yes, Alicorp is a public company listed on LIM.
What is the stock symbol of Alicorp? Alicorp trades under ALICORC1 ticker.
When did Alicorp go public? Alicorp went public in 1995.
Who are competitors of Alicorp? Similar companies to Alicorp include e.g. Acme United, EZZ Life Science, Lavipharm, Sarantis Group.
What is the current market cap of Alicorp? Alicorp's current market cap is $1.6B
What is the current revenue of Alicorp? Alicorp's last 12 months revenue is $3.5B.
What is the current revenue growth of Alicorp? Alicorp revenue growth (NTM/LTM) is 8%.
What is the current EV/Revenue multiple of Alicorp? Current revenue multiple of Alicorp is 0.8x.
Is Alicorp profitable? Yes, Alicorp is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Alicorp? Alicorp's last 12 months EBITDA is $523M.
What is Alicorp's EBITDA margin? Alicorp's last 12 months EBITDA margin is 15%.
What is the current EV/EBITDA multiple of Alicorp? Current EBITDA multiple of Alicorp is 5.1x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.